A strategic review on the involvement of receptors, transcription factors and hormones in acne pathogenesis

References

• Abhishek B, Garima D. Development and characterization of a novel antiacne niosomal gel of rosmarinic acid. Drug Deliv. 2015;22:723–730.
   PubMed Web of Science ®Google Scholar
• Chakraborty D, Mandal SM, Chakraborty J, et al. Antimicrobial activity of leaf extract of Basilicum polystachon (L) Moench. Indian J Exp Biol. 2007;45:744–748.
   PubMed Web of Science ®Google Scholar
• Ogundare AO, Salawu SO. Antimicrobial activities of phenolic containing extract of some tropical vegetables. Afr J Pharm Pharacol. 2011;5:486–492.
   Web of Science ®Google Scholar
• Simonoska M, Dodov MG. Formulation and characterisation of topical liposome gel bearing lidocaine hcl. Bull Chem. 2005;24:59–65.
   Google Scholar
• O'Neill AM, Gallo RL. Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris. Microbiome. 2018;6:177.
   PubMed Web of Science ®Google Scholar
• Halvorsen JA, Stern RS, Dalgard F, et al. Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study. J Invest Dermatol. 2011;131:363–370.
   PubMed Web of Science ®Google Scholar
• Oh J, Byrd AL, Deming C, et al.; NISC Comparative Sequencing Program. Biogeography and individuality shape function in the human skin metagenome. Nature. 2014;514:59–64.
   PubMed Web of Science ®Google Scholar
• Linfante A, Allawh RM, Allen HB. The role of Propionibacterium acnes biofilm in acne vulgaris. J Clin Exp Dermatol Res. 2018;9:439.
   Google Scholar
• Collier CN, Harper JC, Cantrell WC, et al. Нe prevalence of acne in adults 20 years and older. J Am Acad Dermatol. 2008;58:56–59.
   PubMed Web of Science ®Google Scholar
• Andrew A, James QR, Seemal RD, et al. Minocycline topical gel shows promise for the treatment of moderate-to-severe inflammatory acne vulgaris. J Clin Aesthet Dermatol. 2018;11:25–35.
   Google Scholar
• Weiss JS. Acne: evolving concepts of pathogenesis need to guide therapeutic developments. J Drugs Dermatol. 2013;12:s66.
   PubMed Web of Science ®Google Scholar
• Thiboutot DM, Dreno B, Abanmi A, et al. Practical management of acne for clinicians: an international consensus from the Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2018;78:S1–S23.
   PubMed Web of Science ®Google Scholar
• Strauss JS, Krowchuk DP, Leyden JJ, et al.; American Academy of Dermatology/American Academy of Dermatology Association. Guidelines of care for acne vulgaris management. J Am Acad Dermatol. 2007;56:651–663.
   PubMed Web of Science ®Google Scholar
• Magin P, Adams J, Heading G, et al. Psychological sequelae of acne vulgaris: results of a qualitative study. Can Fam Physician. 2006;52:978–979.
   PubMedGoogle Scholar
• Jappe U. Pathological mechanisms of acne with special emphasis on Propionibacterium acnes and related therapy. Acta Derm Venereol. 2003;83:241–248.
   PubMed Web of Science ®Google Scholar
• Fleming A. On the etiology of acne vulgaris and its treatment by vaccines. Lancet. 1909;173:1035–1038.
   Google Scholar
• Strauss JS, Kligman AM. The pathologic dynamics of acne vulgaris. Arch Dermatol. 1960;82:779–791.
   Google Scholar
• Leeming JP, Holland KT, Cuncliffe WJ. The microbial colonization of inflamed acne vulgaris lesions. Br J Dermatol. 1988;118:203–208.
   PubMed Web of Science ®Google Scholar
• Dessinioti C, Katsambas AD. The role of Propionibacterium acnes in acne pathogenesis: facts and controversies. Clin Dermatol. 2010;28:2–7.
   PubMed Web of Science ®Google Scholar
• Li X, He C, Chen Z, et al. A review of the role of sebum in the mechanism of acne pathogenesis. J Cosmet Dermatol. 2017;16:168–173.
   PubMed Web of Science ®Google Scholar
• Evgenia M, Ganceviciene r, Christos Z. An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatoendocrinol. 2011;3:41–49.
   PubMedGoogle Scholar
• Zouboulis CC, Schagen S, Alestas T. The sebocyte culture: a model to study the pathophysiology of the sebaceous gland in sebostasis, seborrhoea and acne. Arch Dermatol Res. 2008;300:397–413.
   PubMed Web of Science ®Google Scholar
• Bakry OA, El Shazly RM, El Farargy SM, et al. Role of hormones and blood lipids in the pathogenesis of acne vulgaris in non-obese, non-hirsute females. Indian Dermatol Online J. 2014;5:9–16.
   Google Scholar
• Choi CW, Choi JW, Park KC, et al. Facial sebum affects the development of acne, especially the distribution of inflammatory acne. J Eur Acad Dermatol Venereol. 2013;27:301–306.
   PubMed Web of Science ®Google Scholar
• Marisa T, Maria G, Rebecca P. Pathways to inflammation: acne pathophysiology. Eur J Dermatol. 2011;21:323–333.
   PubMed Web of Science ®Google Scholar
• Kurokawa I, Danby FW, Ju Q, et al. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol. 2009;18:821–822.
   PubMed Web of Science ®Google Scholar
• Nettis E, Colanardi MC, Ferrannini A, et al. Antihistamines as important tools for regulating inflammation. CMCAIAA. 2005;4:81–89.
   Google Scholar
• Pelle E, McCarthy J, Seltmann H, et al. Identification of Histamine Receptors and Reduction of Squalene Levels by an Antihistamine in Sebocytes. J Invest Dermatol. 2008;128:1280–1285.
   PubMed Web of Science ®Google Scholar
• Smith TM, Cong Z, Gilliland KL, et al. Insulin-like growth factor-1 induces lipid production in human SEB-1 sebocytes via sterol response element-binding protein-1. J Invest Dermatol. 2006;126:1226–1232.
   PubMed Web of Science ®Google Scholar
• Maruko T, Nakahara T, Sakamoto K, et al. Involvement of the βγ subunits of G proteins in the cAMP response induced by stimulation of the histamine H1 receptor. Naunyn Schmiedebergs Arch Pharmacol. 2005;372:153–159.
   PubMed Web of Science ®Google Scholar
• Bastien J, Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene. 2004;328:1–16.
   PubMed Web of Science ®Google Scholar
• Duong V, Rochette-Egly C. The molecular physiology of nuclear retinoic acid receptors. From health to disease. Biochim Biophys Acta. 2011;1812:1023–1031.
   PubMed Web of Science ®Google Scholar
• de The H, Marchio A, Tiollais P, et al. Differential expression and ligand regulation of the retinoic acid receptor alpha and beta genes. Embo J. 1989;8:429–433.
   PubMed Web of Science ®Google Scholar
• Toulouse A, Morin J, Pelletier M, et al. Structure of the human retinoic acid receptor beta 1 gene. Biochim Biophys Acta. 1996;1309:1–4.
   PubMed Web of Science ®Google Scholar
• Alvarez S, Germain P, Alvarez R, et al. Structure, function and modulation of retinoic acid receptor beta, a tumor suppressor. Int J Biochem Cell Biol. 2007;39:1406–1415.
   PubMed Web of Science ®Google Scholar
• Sun SY, Lotan R. Retinoids and their receptors in cancer development and chemoprevention. Critical Rev Oncology/Hematology. 2002;41:41–55.
   PubMed Web of Science ®Google Scholar
• Alvarez S, Bourguet W, Gronemeyer H, et al. Retinoic acid receptor modulators: a perspective on recent advances and promises. Expert Opin Ther Pat. 2011;21:55–63.
   PubMed Web of Science ®Google Scholar
• Chapellier M, Mark N, Messaddeq C, et al. Physiological and retinoid-induced proliferations of epidermis basal keratinocytes are differently controlled. Embo J. 2002;21:3402–3413.
   PubMed Web of Science ®Google Scholar
• van de Kerkhof PC. Update on retinoid therapy of psoriasis in: an update on the use of retinoids in dermatology. Dermatol Ther. 2006;19:252–263.
   PubMed Web of Science ®Google Scholar
• Czernielewski J, Michel S, Bouclier M, et al. Adapalene biochemistry and the evolution of a new topical retinoid for treatment of acne. J Eur Acad Dermatol Venereol. 2001;15:5–12.
   PubMed Web of Science ®Google Scholar
• Beckenbach L, Baron JM, Merk HF, et al. Retinoid treatment of skin diseases. Eur J Dermatol. 2015;25:384–391.
   PubMed Web of Science ®Google Scholar
• Yeh L, Bonati LM, Silverberg NB. Topical retinoids for acne. Semin Cutan Med Surg. 2016;35:50–56.
   PubMed Web of Science ®Google Scholar
• Bodo CM, Gerd S, Christos CZ. Anti-Acne Agents Attenuate FGFR2 Signal Transduction in Acne. J Invest Dermatol. 2009;129:1868–1877.
   PubMed Web of Science ®Google Scholar
• Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 2005;16:139–149.
   PubMed Web of Science ®Google Scholar
• Grose R, Fantl V, Werner S, et al. The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development. Embo J. 2007;26:1268–1278.
   PubMed Web of Science ®Google Scholar
• De Giorgi V, Sestini S, Massi D, et al. Keratinocyte growth factor receptors. Dermatol Clin. 2007;25:477–485.
   PubMed Web of Science ®Google Scholar
• De Moerlooze L, Spencer-Dene B, Revest JM, et al. An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development. 2000;127:483–492.
   PubMed Web of Science ®Google Scholar
• Ong SH, Guy GR, Hadari YR, et al. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors. Mol Cell Biol. 2000;20:979–989.
   PubMed Web of Science ®Google Scholar
• Wong A, Lamothe B, Lee A, et al. FRS2 alpha attenuates FGF receptor signaling by Grb2-mediated recruitment of the ubiquitin ligase Cbl. Proc Natl Acad Sci USA. 2002;99:6684–6689.
   PubMed Web of Science ®Google Scholar
• Belleudi F, Leone L, Nobili V, et al. Keratinocyte growth factor receptor ligands target the receptor to different intracellular pathways. Traffic. 2007;8:1854–1872.
   PubMed Web of Science ®Google Scholar
• Ahmed Z, Schuller AC, Suhling K, et al. Extracellular point mutations in FGFR2 elicit unexpected changes in intracellular signalling. Biochem J. 2008;413:37–49.
   PubMed Web of Science ®Google Scholar
• Melnik B, Schmitz G. FGFR2 signaling and the pathogenesis of acne. J Dtsch Dermatol Ges. 2008;6:721–728.
   PubMed Web of Science ®Google Scholar
• Ding W, Shi W, Bellusci S, et al. Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells. J Cell Physiol. 2007;212:796–806.
   PubMed Web of Science ®Google Scholar
• Whitney V, SadeghA BB. The expression of toll-like receptors in dermatological diseases and the therapeutic effect of current and newer topical toll-like receptor modulators. J Clin Aesthet Dermatol. 2010;3:20–29.
   Google Scholar
• Lai Y, Gallo RL. Toll-like receptors in skin infections and inflammatory diseases. Infect Disord Drug Targets. 2008;8:144–155.
   PubMedGoogle Scholar
• Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. 2007;13:460–469.
   PubMed Web of Science ®Google Scholar
• Miller LS. Toll-like receptors in skin. Adv Dermatol. 2008;24:71–87.
   PubMedGoogle Scholar
• Sandor F, Buc M. Toll-like receptors. I. Structure, function and their ligands. Folia Biol (Praha). 2005;51:148–157.
   PubMed Web of Science ®Google Scholar
• Kang SS, Kauls LS, Gaspari AA. Toll-like receptors: applications to dermatologic disease. J Am Acad Dermatol. 2006;54:951–983.
   PubMed Web of Science ®Google Scholar
• McInturff JE, Modlin RL, Kim J. The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Invest Dermatol. 2005;125:1–8.
   PubMed Web of Science ®Google Scholar
• McInturff JE, Kim J. The role of toll-like receptors in the pathophysiology of acne. Semin Cutan Med Surg. 2005;24:73–78.
   PubMed Web of Science ®Google Scholar
• Kim J, Ochoa MT, Krutzik SR, et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol. 2002;169:1535–1541.
   PubMed Web of Science ®Google Scholar
• Marta GM, Coulson R, Rubinchik E. Anti-inflammatory activity of cationic peptides: application to the treatment of acne vulgaris. FEMS Microbiol Lett. 2006;257:1–6.
   PubMed Web of Science ®Google Scholar
• Melnik BC. Acneigenic stimuli converge in phosphoinositol-3 kinase/Akt/FoxO1 signal transduction. J Clin Exp Dermatol Res. 2010;1:101.
   Google Scholar
• Norman RJ, Dewailly D, Legro RS, et al. Polycystic ovary syndrome. Lancet. 2007;370:685–697.
   PubMed Web of Science ®Google Scholar
• Corbould A. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes? Panminerva Med. 2008;50:279–294.
   PubMed Web of Science ®Google Scholar
• Vigouroux C. What have we learned form monogenic forms of severe insulin resistance associated with PCOS/HAIRAN? Ann Endocrinol (Paris). 2010;71:222–224.
   PubMed Web of Science ®Google Scholar
• Thielitz A, Reinhold D, Vetter R, et al. Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation. J Invest Dermatol. 2007;127:1042–1051.
   PubMed Web of Science ®Google Scholar
• Jeremy AH, Holland DB, Roberts SG, et al. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol. 2003;121:20–27.
   PubMed Web of Science ®Google Scholar
• Becker T, Loch G, Beyer M, et al. FOXO-dependent regulation of innate immune homeostasis. Nature. 2010;463:369–373.
   PubMed Web of Science ®Google Scholar
• Peng SL. Foxo in the immune system. Oncogene. 2008;27:2337–2344.
   PubMed Web of Science ®Google Scholar
• Ouyang W, Beckett O, Flavell RA, et al. An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance. Immunity. 2009;30:358–371.
   PubMed Web of Science ®Google Scholar
• Ansorge S, Bank U, Heimburg A, et al. Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions. Clin Chem Lab Med. 2009;47:253–261.
   PubMed Web of Science ®Google Scholar
• Böhm M. Neuroendocrine regulators: novel trends in sebaceous gland research with future perspectives for the treatment of acne and related disorders. Dermatoendocrinol. 2009;1:136–140.
   PubMedGoogle Scholar
• Ganceviciene R, Böhm M, Fimmel S, et al. The role of neuropeptides in the multifactorial pathogenesis of acne vulgaris. Dermatoendocrinol. 2009;1:170–176.
   PubMedGoogle Scholar
• Krause K, Schnitger A, Fimmel S, et al. Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands. Horm Metab Res. 2007;39:166–170.
   PubMed Web of Science ®Google Scholar
• Chandras C, Koutmani Y, Kokkotou E, et al. Activation of phosphatidylinositol 3-kinase/protein kinase B by corticotropin-releasing factor in human monocytes. Endocrinology. 2009;150:4606–4614.
   PubMed Web of Science ®Google Scholar
• Jiann-Jyh L, Philip C, Kuo-Pao L, et al. The role of androgen and androgen receptor in the skin related disorders. Arch Dermatol Res. 2012;304:499–510.
   PubMed Web of Science ®Google Scholar
• Chen W, Thiboutot D, Zouboulis CC. Cutaneous androgen metabolism: basic research and clinical perspectives. J Invest Dermatol. 2002;119:992–1007.
   PubMed Web of Science ®Google Scholar
• Rohini P, Shipra P, Ashish KM. Epidermal androgen receptors in acne vulgaris patients before and following oral isotretinoin. J Anat Soc India. 2015;64:42–47.
   Web of Science ®Google Scholar
• Zouboulis CC, Degitz K. Androgen action on human skin–from basic research to clinical significance. Exp Dermatol. 2004;13:5–10.
   PubMed Web of Science ®Google Scholar
• Choudhry R, Hodgins MB, Brinkmann AO, et al. Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol. 1992;133:467–475.
   PubMed Web of Science ®Google Scholar
• Fritsch M, Orfanos CE, Zouboulis CC. Sebocytes are the key regulators of androgen homeostasis in human skin. J Invest Dermatol. 2001;116:793–800.
   PubMed Web of Science ®Google Scholar
• Uemura M, Tamura K, Chung S, et al. Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer. Cancer Sci. 2008;99:81–86.
   PubMed Web of Science ®Google Scholar
• Cantagrel V, Lefeber DJ, Guan Z, et al. SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder. Cell. 2010;142:203–217.
   PubMed Web of Science ®Google Scholar
• Seiffert K, Seltmann H, Fritsch M, et al. Inhibition of 5alpha-reductase activity in SZ95 sebocytes and HaCaT keratinocytes in vitro. Horm Metab Res. 2007;39:141–148.
   PubMed Web of Science ®Google Scholar
• Gilliver SC, Ashworth JJ, Mills SJ, et al. Androgens modulate the inflammatory response during acute wound healing. J Cell Sci. 2006;119:722–732.
   PubMed Web of Science ®Google Scholar
• van de Wijngaart DJ, Dubbink HJ, van Royen ME, et al. Androgen receptor coregulators: recruitment via the coactivator binding groove. Mol Cell Endocrinol. 2012;352:57–69.
   PubMed Web of Science ®Google Scholar
• Melnik BC. Role of FGFR2-signaling in the pathogenesis of acne. Dermatoendocrinol. 2009;1:141–156.
   PubMedGoogle Scholar
• Melnik BC. FoxO1 – the key for the pathogenesis and therapy of acne? J Dtsch Dermatol Ges. 2010;8:105–114.
   PubMed Web of Science ®Google Scholar
• Ben-Amitai D, Laron Z. Effect of insulin-like growth factor-1 deficiency or administration on the occurrence of acne. J Eur Acad Dermatol Venereol. 2011;25:950–954.
   PubMed Web of Science ®Google Scholar
• Smith TM, Gilliland K, Clawson GA, et al. IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway. J Invest Dermatol. 2008;128:1286–1293.
   PubMed Web of Science ®Google Scholar
• Vora S, Ovhal A, Jerajani H, et al. Correlation of facial sebum to serum insulin-like growth factor-1 in patients with acne. Br J Dermatol. 2008;159:990–991.
   PubMed Web of Science ®Google Scholar
• Hyojin K, Moon SY, Sohn MY, et al. Insulin-like growth factor-1 increases the expression of inflammatory biomarkers and sebum production in cultured sebocytes. Ann Dermatol. 2017;29:20–25.
   PubMed Web of Science ®Google Scholar
• Melnik BC. Isotretinoin and FoxO1: a scientific hypothesis. Dermatoendocrinol. 2011;3:141–165.
   PubMedGoogle Scholar
• Lai JJ, Lai KP, Chuang KH, et al. Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression. J Clin Invest. 2009;119:3739–3751.
   PubMed Web of Science ®Google Scholar
• Chuang KH, Altuwaijri S, Li G, et al. Neutropenia with impaired host defense against microbial infection in mice lacking androgen receptor. J Exp Med. 2009;206:1181–1199.
   PubMed Web of Science ®Google Scholar
• Cyrulnik AA, Viola KV, Gewirtzman AJ, et al. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life. Int J Dermatol. 2012;51:1123–1130.
   PubMed Web of Science ®Google Scholar
• Wilson CM, McPhaul MJ. A and B forms of the androgen receptor are expressed in a variety of human tissues. Mol Cell Endrocrinol. 1996;120:51–57.
   PubMed Web of Science ®Google Scholar
• Iwamura M, Abrahamsson P, Benning CM, et al. Androgen receptor immunostaining and its tissue distribution in formalin-fixed, paraffin-embedded sections after microwave treatment. J Histochem Cytochem. 1994;42:783–788.
   PubMed Web of Science ®Google Scholar
• Bakry OA, Farargy SM, Din NN, et al. Immunohistochemical expression of cyclo-oxygenase 2 and liver X receptor-α in acne vulgaris. J Clin Diagn Res. 2017;11:WC01–WC07.
   PubMed Web of Science ®Google Scholar
• Gupta DS, Kaul D, Kanwar AJ, et al. Psoriasis: crucial role of LXR-alpha RNomics. Genes Immun. 2010;11:37–44.
   PubMed Web of Science ®Google Scholar
• Schmuth M, Jiang YJ, Dubrac S, et al. Thematic review series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology . J Lipid Res. 2008;49:499–509.
   PubMed Web of Science ®Google Scholar
• Alberti S, Steffensen KR, Gustafsson JA. Structural characterisation of the mouse nuclear oxysterol receptor genes LXRalpha and LXRbeta. Gene. 2000;243:93–103.
   PubMed Web of Science ®Google Scholar
• Hong I, Lee MH, Zouboulis CC, et al. LXRalpha enhances lipid synthesis in SZ95 sebocytes. J Invest Dermatol. 2008;128:1266–1272.
   PubMed Web of Science ®Google Scholar
• Russell LE, Harrison WJ, Bahta AW, et al. Characterization of liver X receptor expression and function in human skin and the pilosebaceous unit. Exp Dermatol. 2007;16:844–852.
   PubMed Web of Science ®Google Scholar
• Lu TT, Repa JJ, Mangelsdorf DJ. Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism. J Biol Chem. 2001;276:37735–37738.
   PubMed Web of Science ®Google Scholar
• Bohm M, Luger TA, Tobin DJ, et al. Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology. J Invest Dermatol. 2006;126:1966–1975.
   PubMed Web of Science ®Google Scholar
• Slominski A, Wortsman J, Plonka PM, et al. Hair follicle pigmentation. J Invest Dermatol. 2005;124:13–21.
   PubMed Web of Science ®Google Scholar
• Brzoska T, Luger TA, Maaser C, et al. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases . Endocr Rev. 2008;29:581–602.
   PubMed Web of Science ®Google Scholar
• Zhang L, Anthonavage M, Eisinger M, et al. Melanocortin-5 receptor: a marker of human sebocyte differentiation. Peptides. 2006;27:413–420.
   PubMed Web of Science ®Google Scholar
• Moustafa M, Szabo M, Ghanem GE, et al. Inhibition of tumor necrosis factor-alpha stimulated NFkappaB/p65 in human keratinocytes by alpha-melanocyte stimulating hormone and adrenocorticotropic hormone peptides. J Invest Dermatol. 2002;119:1244–1253.
   PubMed Web of Science ®Google Scholar
• Spencer JD, Schallreuter KU. Regulation of pigmentation in human epidermal melanocytes by functional high-affinity beta-melanocyte-stimulating hormone/melanocortin-4 receptor signaling. Endocrinology. 2009;150:1250–1258.
   PubMed Web of Science ®Google Scholar
• Bohm M, Luger TA. Melanocortins in fibroblast biology–current update and future perspective for dermatology. Exp Dermatol. 2004;13:16–21.
   PubMed Web of Science ®Google Scholar
• Rosenfield RL, Wu PP, Ciletti N. Sebaceous epithelial cell differentiation requires cyclic adenosine monophosphate generation. In Vitro Cell Dev Biol Anim. 2002;38:54–57.
   PubMed Web of Science ®Google Scholar
• Huang Q, Anthonavage M, Eisinger M, et al. The role of α-MSH in human sebaceous lipogenesis. J Invest Dermatol. 2002;119:275.
   Web of Science ®Google Scholar
• Zhang L, Li WH, Anthonavage M, et al. Melanocortin-5 receptor and sebogenesis. Eur J Pharmacol. 2011;660:202–206.
   PubMed Web of Science ®Google Scholar
• Ferre P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes. 2004;53:S43–S50.
   PubMed Web of Science ®Google Scholar
• Knouff C, Auwerx J. Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacology. Endocr Rev. 2004;25:899–918.
   PubMed Web of Science ®Google Scholar
• Desvergne B, Michalik L, Wahli W. Be fit or be sick: peroxisome proliferator-activated receptors are down the road. Mol Endocrinol. 2004;18:1321–1332.
   PubMed Web of Science ®Google Scholar
• van Raalte DH, Li M, Pritchard PH, et al. Peroxisome proliferator-activated receptor (PPAR)-alpha: a pharmacological target with a promising future. Pharm Res. 2004;21:1531–1538.
   PubMed Web of Science ®Google Scholar
• Fazio S, Linton MF. The role of fibrates in managing hyperlipidemia: mechanisms of action and clinical efficacy. Curr Atheroscler Rep. 2004;6:148–157.
   PubMedGoogle Scholar
• Schmuth M, Haqq C, Cairns W, et al. Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes. J Invest Dermatol. 2004;122:971–983.
   PubMed Web of Science ®Google Scholar
• Mao-Qiang M, Fowler A, Schmuth M, et al. Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation . J Invest Dermatol. 2004;123:305–312.
   PubMed Web of Science ®Google Scholar
• Chen W, Yang C, Sheu H, et al. Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol. 2003;121:441–447.
   PubMed Web of Science ®Google Scholar
• Downie MM, Sanders D, Maier L, et al. Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro. Br J Dermatol. 2004;151:766–775.
   PubMed Web of Science ®Google Scholar
• Alestas T, Ganceviciene R, Fimmel S, et al. Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. J Mol Med. 2006;84:75–87.
   PubMed Web of Science ®Google Scholar
• Schuster M, Zouboulis CC, Ochsendorf F, et al. Peroxisome proliferator-activated receptor activators protect sebocytes from apoptosis: a new treatment modality for acne? Br J Dermatol. 2011;164:182–186.
   PubMed Web of Science ®Google Scholar
• Trivedi NR1, Cong Z, Nelson AM, et al. Peroxisome proliferator-activated receptors increase human sebum production. J Invest Dermatol. 2006;126:2002–2009.
   PubMed Web of Science ®Google Scholar
• Kim HK, Yeo IK, Kim BJ, et al. Topical epidermal growth factor for the improvement of acne lesions: a randomized, double-blinded, placebo-controlled, split-face trial. Int J Dermatol. 2014;53:1031–1036.
   PubMed Web of Science ®Google Scholar
• Wollenberg A, Kroth J, Hauschild A, et al. [Cutaneous side effects of EGFR inhibitors-appearance and management]. Dtsch Med Wochenschr. 2010;135:149–154.
   PubMed Web of Science ®Google Scholar
• Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med. 2008;358:1160–1174.
   PubMed Web of Science ®Google Scholar
• Harari M, Allen GW, Bonner JA. Biology of interactions: antiepidermal growth factor receptor agents. J Clin Oncol. 2007;25:4057–4065.
   PubMed Web of Science ®Google Scholar
• Pastore S, Mascia F. Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin. Expert Rev Dermatol. 2008;3:525–527.
   PubMedGoogle Scholar
• Koff JL, Shao MX, Ueki IF, et al. Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium. Am J Physiol Lung Cell Mol Physiol. 2008;294:1068–1075.
   Web of Science ®Google Scholar
• Grange PA, Raingeaud J, Calvez V, et al. Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-kappaB and MAPK pathways. J Dermatol Sci. 2009;56:106–112.
   PubMed Web of Science ®Google Scholar
• Dahlhoff M, de Angelis MH, Wolf E, et al. Ligand-independent epidermal growth factor receptor hyperactivation increases sebaceous gland size and sebum secretion in mice. Exp Dermatol. 2013;22:667–669.
   PubMed Web of Science ®Google Scholar